Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,697,352 papers from all fields of science
Search
Sign In
Create Free Account
ivacaftor 125 MG / lumacaftor 200 MG Oral Tablet [ORKAMBI]
Known as:
ORKAMBI (lumacaftor 200 MG / ivacaftor 125 MG) Oral Tablet
, ORKAMBI 200 MG / 125 MG Oral Tablet
, lumacaftor 200 mg / ivacaftor 125 mg ORAL TABLET, FILM COATED [ORKAMBI]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Ammonia
Brilliant blue FCF
Croscarmellose Sodium
HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2-S)
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
S13.2 The Swedish cystic fibrosis Registry facilitates the evaluation of Orkambi® treatment
P. Ericson
,
A. Hedborg
,
+6 authors
A. Lindblad
2020
Corpus ID: 219749739
2019
2019
Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation
O. Laselva
,
S. Erwood
,
K. Du
,
Z. Ivakine
,
C. Bear
FASEB bioAdvances
2019
Corpus ID: 202854026
F508del‐cystic fibrosis transmembrane conductance regulator (CFTR) is the major mutant responsible for cystic fibrosis (CF…
Expand
2018
2018
Case History: Orkambi® (Ivacaftor/Lumacaftor), for the Treatment of Cystic Fibrosis Patients who are Homozygous for the F508del CFTR Mutation
Sabine Hadida
,
F. Goor
,
P. Negulescu
,
P. Grootenhuis
Medicinal Chemistry Reviews
2018
Corpus ID: 81155861
2017
2017
ORKAMBI®, Zystische Fibrose (CF, Mukoviszidose) | STO
Sto Pharmawerbung Ag
2017
Corpus ID: 200732907
Fachkommunikation (Sales Folder, DDI Facher) Patientenkommunikation (Therapiestart, Ernahrungshinweise) Patientenkommunikation…
Expand
2017
2017
Lumacaftor-Ivacaftor combination therapy in Phe508del homozygous CF patients with end-stage lung disease – preliminary results
C. Murer
,
L. Huber
,
+4 authors
C. Benden
2017
Corpus ID: 79574786
Objectives: Recently, the combination of CFTR potentiator ivacaftor and CFTR corrector lumacaftor (Orkambi®) has been shown to…
Expand
2016
2016
Cystische Fibrose: aktuelle Studien – neue Medikamente
Cystische Fibrose
Pädiatrie & Pädologie
2016
Corpus ID: 26466050
F Die Präsentationen beinhalteten neue Real World Daten aus einer noch andauernden fünfjährigen Beobachtungstudie, die die…
Expand
2015
2015
Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference…
A. Verkman
,
A. Edelman
,
+5 authors
C. Bear
Journal of Cystic Fibrosis
2015
Corpus ID: 23299978
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE